Related references
Note: Only part of the references are listed.Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival
Afroditi Nanou et al.
BRITISH JOURNAL OF CANCER (2020)
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
Silke Gillessena et al.
EUROPEAN UROLOGY (2020)
Role of androgen receptor splice variants, their clinical relevance and treatment options
S. Wach et al.
WORLD JOURNAL OF UROLOGY (2020)
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
Wojciech A. Cieslikowski et al.
CANCERS (2020)
Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
Mercedes Marin-Aguilera et al.
CELLS (2020)
Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer
Dingxiao Zhang et al.
NATURE COMMUNICATIONS (2020)
Multimodal Targeted Deep Sequencing of Circulating Tumor Cells and Matched Cell-Free DNA Provides a More Comprehensive Tool to Identify Therapeutic Targets in Metastatic Breast Cancer Patients
Corinna Keup et al.
CANCERS (2020)
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer
Laura Cato et al.
CANCER CELL (2019)
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
Andrew J. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer
Corinna Keup et al.
CANCERS (2019)
In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy
Shukun Chen et al.
CANCERS (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells
Amin El-Heliebi et al.
CLINICAL CHEMISTRY (2018)
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
Jun Luo et al.
EUROPEAN UROLOGY (2018)
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide
Jelena Belic et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Treatment-induced changes in the androgen receptor axis: Liquid biopsies as diagnostic/prognostic tools for prostate cancer
S. Prekovic et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer
Fangfang Qu et al.
CLINICAL CANCER RESEARCH (2017)
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer
Howard I. Scher et al.
EUROPEAN UROLOGY (2017)
AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide
Anna Katharina Seitz et al.
EUROPEAN UROLOGY (2017)
AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone Acetate
Tilman Todenhoefer et al.
JOURNAL OF UROLOGY (2017)
Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing
Anders Stahlberg et al.
NATURE PROTOCOLS (2017)
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
Viktor A. Adalsteinsson et al.
NATURE COMMUNICATIONS (2017)
Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer
Howard I. Scher et al.
CANCER RESEARCH (2017)
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance
Manish Kohli et al.
CLINICAL CANCER RESEARCH (2017)
Plexin-B1 signalling promotes androgen receptor translocation to the nucleus
M. Williamson et al.
ONCOGENE (2016)
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
Peter Ulz et al.
NATURE COMMUNICATIONS (2016)
Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®
Tobias M. Gorges et al.
PLOS ONE (2016)
Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients
Andra Kuskel et al.
SCIENTIFIC REPORTS (2016)
Detection of AR-V7 mRNA in whole blood may not predict the effectiveness of novel endocrine drugs for castration-resistant prostate cancer
Takumi Takeuchi et al.
RESEARCH AND REPORTS IN UROLOGY (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Are androgen receptor variants a substitute for the full-length receptor?
Ji Lu et al.
NATURE REVIEWS UROLOGY (2015)
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
David T. Miyamoto et al.
SCIENCE (2015)
Plasma AR and abiraterone-resistant prostate cancer
Alessandro Romanel et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Expression of androgen receptor splice variants in clinical breast cancers
Theresa E. Hickey et al.
ONCOTARGET (2015)
Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Emmanuel S. Antonarakis et al.
JAMA ONCOLOGY (2015)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mechanisms of the androgen receptor splicing in prostate cancer cells
L. L. Liu et al.
ONCOGENE (2014)
In situ sequencing for RNA analysis in preserved tissue and cells
Rongqin Ke et al.
NATURE METHODS (2013)
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
Ellen Heitzer et al.
GENOME MEDICINE (2013)
Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials
Alexander V. Vlassov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
The Androgen Receptor Gene Mutations Database: 2012 Update
Bruce Gottlieb et al.
HUMAN MUTATION (2012)
Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
Himisha Beltran et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
In situ detection and genotyping of individual mRNA molecules
Chatarina Larsson et al.
NATURE METHODS (2010)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Anne E. Carpenter et al.
GENOME BIOLOGY (2006)
Share Paper
